These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 9770520
1. Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implication for the in vivo delivery of CD8(+) T cell epitopes into antigen-presenting cells. Karimova G, Fayolle C, Gmira S, Ullmann A, Leclerc C, Ladant D. Proc Natl Acad Sci U S A; 1998 Oct 13; 95(21):12532-7. PubMed ID: 9770520 [Abstract] [Full Text] [Related]
2. Characterization of recombinant Bordetella pertussis adenylate cyclase toxins carrying passenger proteins. Gmira S, Karimova G, Ladant D. Res Microbiol; 2001 Dec 13; 152(10):889-900. PubMed ID: 11766964 [Abstract] [Full Text] [Related]
4. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway. Guermonprez P, Ladant D, Karimova G, Ullmann A, Leclerc C. J Immunol; 1999 Feb 15; 162(4):1910-6. PubMed ID: 9973458 [Abstract] [Full Text] [Related]
5. Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis. Dadaglio G, Moukrim Z, Lo-Man R, Sheshko V, Sebo P, Leclerc C. Infect Immun; 2000 Jul 15; 68(7):3867-72. PubMed ID: 10858196 [Abstract] [Full Text] [Related]
6. Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites. Osicka R, Osicková A, Basar T, Guermonprez P, Rojas M, Leclerc C, Sebo P. Infect Immun; 2000 Jan 15; 68(1):247-56. PubMed ID: 10603395 [Abstract] [Full Text] [Related]
7. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity. Fayolle C, Osickova A, Osicka R, Henry T, Rojas MJ, Saron MF, Sebo P, Leclerc C. J Virol; 2001 Aug 15; 75(16):7330-8. PubMed ID: 11462005 [Abstract] [Full Text] [Related]
8. Bioengineering of Bordetella pertussis Adenylate Cyclase Toxin for Antigen-Delivery and Immunotherapy. Chenal A, Ladant D. Toxins (Basel); 2018 Jul 20; 10(7):. PubMed ID: 30037010 [Abstract] [Full Text] [Related]
9. Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes. Dadaglio G, Morel S, Bauche C, Moukrim Z, Lemonnier FA, Van Den Eynde BJ, Ladant D, Leclerc C. Int Immunol; 2003 Dec 20; 15(12):1423-30. PubMed ID: 14645151 [Abstract] [Full Text] [Related]
10. The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells. Simsova M, Sebo P, Leclerc C. Int J Med Microbiol; 2004 Apr 20; 293(7-8):571-6. PubMed ID: 15149033 [Abstract] [Full Text] [Related]
11. Bordetella pertussis adenylate cyclase toxin: a vehicle to deliver CD8-positive T-cell epitopes into antigen-presenting cells. Guermonprez P, Fayolle C, Karimova G, Ullmann A, Leclerc C, Ladant D. Methods Enzymol; 2000 Apr 20; 326():527-42. PubMed ID: 11036662 [No Abstract] [Full Text] [Related]
12. Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells. Sebo P, Fayolle C, d'Andria O, Ladant D, Leclerc C, Ullmann A. Infect Immun; 1995 Oct 20; 63(10):3851-7. PubMed ID: 7558291 [Abstract] [Full Text] [Related]
13. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope. Fayolle C, Ladant D, Karimova G, Ullmann A, Leclerc C. J Immunol; 1999 Apr 01; 162(7):4157-62. PubMed ID: 10201941 [Abstract] [Full Text] [Related]
14. Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo. Fayolle C, Bauche C, Ladant D, Leclerc C. Vaccine; 2004 Dec 16; 23(5):604-14. PubMed ID: 15542180 [Abstract] [Full Text] [Related]
15. Delivery of large heterologous polypeptides across the cytoplasmic membrane of antigen-presenting cells by the Bordetella RTX hemolysin moiety lacking the adenylyl cyclase domain. Holubova J, Kamanova J, Jelinek J, Tomala J, Masin J, Kosova M, Stanek O, Bumba L, Michalek J, Kovar M, Sebo P. Infect Immun; 2012 Mar 16; 80(3):1181-92. PubMed ID: 22215742 [Abstract] [Full Text] [Related]
18. Interaction of calcium with Bordetella pertussis adenylate cyclase toxin. Characterization of multiple calcium-binding sites and calcium-induced conformational changes. Rose T, Sebo P, Bellalou J, Ladant D. J Biol Chem; 1995 Nov 03; 270(44):26370-6. PubMed ID: 7592850 [Abstract] [Full Text] [Related]
19. Delivery of Mycobacterium tuberculosis epitopes by Bordetella pertussis adenylate cyclase toxoid expands HLA-E-restricted cytotoxic CD8+ T cells. Badami GD, La Manna MP, Di Carlo P, Stanek O, Linhartova I, Caccamo N, Sebo P, Dieli F. Front Immunol; 2023 Nov 03; 14():1289212. PubMed ID: 38106407 [Abstract] [Full Text] [Related]
20. Bordetella adenylate cyclase toxin: a unique combination of a pore-forming moiety with a cell-invading adenylate cyclase enzyme. Masin J, Osicka R, Bumba L, Sebo P. Pathog Dis; 2015 Nov 03; 73(8):ftv075. PubMed ID: 26391732 [Abstract] [Full Text] [Related] Page: [Next] [New Search]